Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,498
Recruiting: 782
Ph III recruiting: 85
Growth YoY: +17.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 751–762 of 762 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00496301	Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC(SOGUG-02-06)	completed	Phase 2	40	Spanish Oncology Genito-Urinary GroupOTHER	1	Jan 14, 2009	clinicaltrials
NCT00425204	Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment	completed	Phase 2	31	AmgenINDUSTRY	0	Sep 15, 2008	clinicaltrials